Journal Watch · Biomaterials · 2026

A chrono-modulated oxygen-cycling scaffold reprograms immunometabolism to drive bone regeneration.

By operationalizing stage-specific oxygen control, this platform provides mechanistic insight into oxygen-related disease therapy and guides the design of next-generation oxygen-rhythm biomaterials.

Liu M, Zhang Y, Zhou J et al.Biomaterials3 min readPharma relevance 65/100

DOI: 10.1016/j.biomaterials.2026.124623PMID: 42753576Study type: research study

TL;DR

By operationalizing stage-specific oxygen control, this platform provides mechanistic insight into oxygen-related disease therapy and guides the design of next-generation oxygen-rhythm biomaterials.

Key findings

  • At intermediate and late stages, NIR on activates Cy photosynthesis to release O<sub>2</sub> on demand, transitioning the milieu from hypoxia to reoxygenation, stabilizing neovasculature, and advancing osteogenesis.
  • In a rat critical-sized defect model, this scaffold increased bone volume fraction (BV/TV) by more than 200% compared with controls and achieved early bridging by week 4.
  • By operationalizing stage-specific oxygen control, this platform provides mechanistic insight into oxygen-related disease therapy and guides the design of next-generation oxygen-rhythm biomaterials.

Numbers at a glance (from the abstract)

200%

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

A decellularized, calcined bovine cancellous bone (CCB) scaffold was prepared and subsequently coated with calcium alginate to obtain a calcium alginate-coated CCB (CA@CCB), which provides osteoconductive, bone-mimetic support. Within this scaffold, a module of upconversion nanoparticle (UCNP)-enabled cyanobacteria (Cy) was embedded to program local O<sub>2</sub> dynamics. With NIR off during the early phase, Cy respiration consumes O<sub>2</sub> to establish a reparative hypoxic window.

Full abstract (original)

Background: Bone regeneration is governed by a tightly regulated oxygen rhythm that orchestrates the sequential phases of inflammation, repair, and remodeling. Early hypoxia promotes angiogenic sprouting, whereas subsequent reoxygenation favors vessel maturation and bone matrix deposition. Here, we engineered a near-infrared (NIR)-responsive composite scaffold, UCNP-Cy/CA@CCB, that operationalizes stage-specific oxygen control in vivo.

What they did: A decellularized, calcined bovine cancellous bone (CCB) scaffold was prepared and subsequently coated with calcium alginate to obtain a calcium alginate-coated CCB (CA@CCB), which provides osteoconductive, bone-mimetic support. Within this scaffold, a module of upconversion nanoparticle (UCNP)-enabled cyanobacteria (Cy) was embedded to program local O<sub>2</sub> dynamics. With NIR off during the early phase, Cy respiration consumes O<sub>2</sub> to establish a reparative hypoxic window.

Results & conclusions: At intermediate and late stages, NIR on activates Cy photosynthesis to release O<sub>2</sub> on demand, transitioning the milieu from hypoxia to reoxygenation, stabilizing neovasculature, and advancing osteogenesis. In a rat critical-sized defect model, this scaffold increased bone volume fraction (BV/TV) by more than 200% compared with controls and achieved early bridging by week 4. By operationalizing stage-specific oxygen control, this platform provides mechanistic insight into oxygen-related disease therapy and guides the design of next-generation oxygen-rhythm biomaterials.

Abstract © the authors / Biomaterials (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.biomaterials.2026.124623 · PubMed 42753576.

Why it matters for pharma & biotech

  • Relevant to Biotechnology & Methods teams tracking Biomaterials for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Biomaterials study find?

By operationalizing stage-specific oxygen control, this platform provides mechanistic insight into oxygen-related disease therapy and guides the design of next-generation oxygen-rhythm biomaterials.

What type of study is this?

It is a research study, published in Biomaterials in 2026. A decellularized, calcined bovine cancellous bone (CCB) scaffold was prepared and subsequently coated with calcium alginate to obtain a calcium alginate-coated CCB (CA@CCB), which provides osteoconductive, bone-mimetic support.

Where can I read the original paper?

The original is at the publisher via DOI 10.1016/j.biomaterials.2026.124623. PubMed ID: 42753576. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Liu M, Zhang Y, Zhou J et al.. A chrono-modulated oxygen-cycling scaffold reprograms immunometabolism to drive bone regeneration.. Biomaterials (2026). DOI: 10.1016/j.biomaterials.2026.124623.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/a-chrono-modulated-oxygen-cycling-scaffold-reprograms-immunometabolism-t-124623/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides